Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Updating of in vitro antifungal susceptibility tests.

Castro Méndez C, García Sánchez E, Martín-Mazuelos E.

Enferm Infecc Microbiol Clin. 2019 May;37 Suppl 1:32-39. doi: 10.1016/S0213-005X(19)30180-6. English, Spanish.

PMID:
31138421
2.

A prospective survey of Aspergillus spp. in respiratory tract samples: Species identification and susceptibility patterns.

Castro C, Galán-Sanchez F, Linares MJ, Tejero R, Ruiz M, Serrano ML, Rodríguez-Iglesias M, Martín-Mazuelos E; FUNGAE-IFI Study Group.

Med Mycol. 2019 Jun 1;57(4):412-420. doi: 10.1093/mmy/myy080.

PMID:
30289467
3.

Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study).

Alastruey-Izquierdo A, Alcazar-Fuoli L, Rivero-Menéndez O, Ayats J, Castro C, García-Rodríguez J, Goterris-Bonet L, Ibáñez-Martínez E, Linares-Sicilia MJ, Martin-Gomez MT, Martín-Mazuelos E, Pelaez T, Peman J, Rezusta A, Rojo S, Tejero R, Anza DV, Viñuelas J, Zapico MS, Cuenca-Estrella M; the FILPOP2 Project from GEMICOMED (SEIMC) and REIPI.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00358-18. doi: 10.1128/AAC.00358-18. Print 2018 Sep.

4.

Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Dannaoui E, Garcia-Effron G, Guinea J, Kidd S, Pelaez T, Sanguinetti M, Meletiadis J, Botterel F, Bustamante B, Chen YC, Chakrabarti A, Chowdhary A, Chryssanthou E, Córdoba S, Gonzalez GM, Guarro J, Johnson EM, Kus JV, Lass-Flörl C, Linares-Sicilia MJ, Martín-Mazuelos E, Negri CE, Pfaller MA, Tortorano AM.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01916-17. doi: 10.1128/AAC.01916-17. Print 2018 Apr.

5.

Erratum to: Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.

León C, Ruiz-Santana S, Saavedra P, Castro C, Loza A, Zakariya I, Úbeda A, Parra M, Macías D, Tomás JI, Rezusta A, Rodríguez A, Gómez F, Martín-Mazuelos E; Cava Trem Study Group.

Crit Care. 2017 May 15;21(1):107. doi: 10.1186/s13054-017-1686-1. No abstract available.

6.

Candida albicans Germ-Tube Antibody: Evaluation of a New Automatic Assay for Diagnosing Invasive Candidiasis in ICU Patients.

Parra-Sánchez M, Zakariya-Yousef Breval I, Castro Méndez C, García-Rey S, Loza Vazquez A, Úbeda Iglesias A, Macías Guerrero D, Romero Mejías A, León Gil C, Martín-Mazuelos E; CAVA Trem Study Group.

Mycopathologia. 2017 Aug;182(7-8):645-652. doi: 10.1007/s11046-017-0125-9. Epub 2017 Apr 4.

PMID:
28378240
7.

Case Series Study of Invasive Pulmonary Aspergillosis.

Aller-García AI, Castro-Méndez C, Alastruey-Izquierdo A, Marín-Martínez EM, Breval IZ, Couto-Caro C, López-Marín JC, Peña-Griñán N, Ruiz de Pipaon M, Romero-Mejías AM, Martín-Mazuelos E.

Mycopathologia. 2017 Jun;182(5-6):505-515. doi: 10.1007/s11046-016-0097-1. Epub 2016 Dec 2.

PMID:
27913978
8.

Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.

Espinel-Ingroff A, Arendrup M, Cantón E, Cordoba S, Dannaoui E, García-Rodríguez J, Gonzalez GM, Govender NP, Martin-Mazuelos E, Lackner M, Lass-Flörl C, Linares Sicilia MJ, Rodriguez-Iglesias MA, Pelaez T, Shields RK, Garcia-Effron G, Guinea J, Sanguinetti M, Turnidge J.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01792-16. doi: 10.1128/AAC.01792-16. Print 2017 Jan.

9.

[Epidemiology, risk factors and in vitro susceptibility in candidaemia due to non-Candida albicans species].

Marín Martínez EM, Aller García AI, Martín-Mazuelos E.

Rev Iberoam Micol. 2016 Oct - Dec;33(4):248-252. doi: 10.1016/j.riam.2016.04.003. Epub 2016 Oct 13. Spanish.

PMID:
27746090
10.

Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.

Gago S, Serrano C, Alastruey-Izquierdo A, Cuesta I, Martín-Mazuelos E, Aller AI, Gómez-López A, Mellado E.

Mycoses. 2017 Jan;60(1):40-50. doi: 10.1111/myc.12543. Epub 2016 Sep 15.

PMID:
27633849
11.

Performance of the HSV OligoGen kit for the diagnosis of herpes simplex virus type 1 and 2.

Parra-Sánchez M, Marcuello López A, García-Rey S, Zakariya-Yousef Breval I, Bernal Martínez S, Pueyo Rodríguez I, Martín-Mazuelos E, Palomares Folía JC.

Diagn Microbiol Infect Dis. 2016 Jul;85(3):315-317. doi: 10.1016/j.diagmicrobio.2016.04.019. Epub 2016 Apr 30.

PMID:
27185644
12.

Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.

León C, Ruiz-Santana S, Saavedra P, Castro C, Loza A, Zakariya I, Úbeda A, Parra M, Macías D, Tomás JI, Rezusta A, Rodríguez A, Gómez F, Martín-Mazuelos E; Cava Trem Study Group.

Crit Care. 2016 May 16;20(1):149. doi: 10.1186/s13054-016-1324-3. Erratum in: Crit Care. 2017 May 15;21(1):107.

13.

Performance of the NG OligoGen kit for the diagnosis of Neisseria gonorrhoeae: comparison with cobas 4800 assay.

Parra-Sánchez M, García-Rey S, Marcuello A, Zakariya-Yousef I, Bernal S, Pueyo I, Martín-Mazuelos E, Palomares JC.

Diagn Microbiol Infect Dis. 2016 Jan;84(1):4-6. doi: 10.1016/j.diagmicrobio.2015.09.020. Epub 2015 Oct 9.

PMID:
26508106
14.

β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.

Martín-Mazuelos E, Loza A, Castro C, Macías D, Zakariya I, Saavedra P, Ruiz-Santana S, Marín E, León C.

Intensive Care Med. 2015 Aug;41(8):1424-32. doi: 10.1007/s00134-015-3922-y. Epub 2015 Jul 2.

PMID:
26134359
15.

Comparison of the CT OligoGen kit with cobas 4800 assay for detection of Chlamydia trachomatis.

Parra-Sánchez M, Marcuello-López A, García-Rey S, Zakariya-Yousef I, Sivianes-Valdecantos N, Sierra-Atienza C, Bernal-Martínez S, Pueyo-Rodrígez I, Martín-Mazuelos E, Palomares-Folía JC.

Enferm Infecc Microbiol Clin. 2015 Dec;33(10):642-5. doi: 10.1016/j.eimc.2015.02.017. Epub 2015 Apr 6.

PMID:
25858681
16.

Comparison of urine and cervical samples for detecting human papillomavirus (HPV) with the Cobas 4800 HPV test.

Bernal S, Palomares JC, Artura A, Parra M, Cabezas JL, Robles A, Martín Mazuelos E.

J Clin Virol. 2014 Dec;61(4):548-52. doi: 10.1016/j.jcv.2014.10.001. Epub 2014 Oct 12.

PMID:
25453566
17.

Impact of therapeutic strategies on the prognosis of candidemia in the ICU.

Puig-Asensio M, Pemán J, Zaragoza R, Garnacho-Montero J, Martín-Mazuelos E, Cuenca-Estrella M, Almirante B; Prospective Population Study on Candidemia in Spain (CANDIPOP) Project; Hospital Infection Study Group (GEIH); Medical Mycology Study Group (GEMICOMED) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC); Spanish Network for Research in Infectious Diseases.

Crit Care Med. 2014 Jun;42(6):1423-32. doi: 10.1097/CCM.0000000000000221.

PMID:
24557426
18.

Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.

Espinel-Ingroff A, Pfaller MA, Bustamante B, Canton E, Fothergill A, Fuller J, Gonzalez GM, Lass-Flörl C, Lockhart SR, Martin-Mazuelos E, Meis JF, Melhem MS, Ostrosky-Zeichner L, Pelaez T, Szeszs MW, St-Germain G, Bonfietti LX, Guarro J, Turnidge J.

Antimicrob Agents Chemother. 2014;58(4):2006-12. doi: 10.1128/AAC.02615-13. Epub 2014 Jan 13.

19.

Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.

Guinea J, Zaragoza Ó, Escribano P, Martín-Mazuelos E, Pemán J, Sánchez-Reus F, Cuenca-Estrella M; CANDIPOP Project, GEIH-GEMICOMED (SEIMC), and REIPI.

Antimicrob Agents Chemother. 2014;58(3):1529-37. doi: 10.1128/AAC.02155-13. Epub 2013 Dec 23.

20.

Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method.

Pfaller MA, Espinel-Ingroff A, Bustamante B, Canton E, Diekema DJ, Fothergill A, Fuller J, Gonzalez GM, Guarro J, Lass-Flörl C, Lockhart SR, Martin-Mazuelos E, Meis JF, Ostrosky-Zeichner L, Pelaez T, St-Germain G, Turnidge J.

Antimicrob Agents Chemother. 2014;58(2):916-22. doi: 10.1128/AAC.02020-13. Epub 2013 Nov 25.

21.

Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method.

Espinel-Ingroff A, Chowdhary A, Gonzalez GM, Lass-Flörl C, Martin-Mazuelos E, Meis J, Peláez T, Pfaller MA, Turnidge J.

Antimicrob Agents Chemother. 2013 Aug;57(8):3823-8. doi: 10.1128/AAC.00636-13. Epub 2013 May 28.

22.

[Microbiological procedures for the diagnosis, management, and study of invasive fungal infections].

Canton E, García-Rodríguez J, Martín-Mazuelos E, Pemán J, Guinea J.

Enferm Infecc Microbiol Clin. 2014 Jun-Jul;32(6):375-9. doi: 10.1016/j.eimc.2013.01.008. Epub 2013 Mar 15. Spanish.

PMID:
23499525
23.

[Age group, geographical incidence and patterns of antifungal susceptibility of Candida species causing candidemia in the Spanish paediatric population].

García-Rodríguez J, Cantón E, Pemán J, Alvarez M, Ezpeleta G, Gómez-Nieto A, Iglesias I, Martín-Mazuelos E, Ramírez-de Ocariz I, Rezusta A, Royo-García G; Grupo de Estudio FUNGEMYCA.

Enferm Infecc Microbiol Clin. 2013 Jun-Jul;31(6):363-8. doi: 10.1016/j.eimc.2012.09.018. Epub 2013 Feb 8. Spanish.

PMID:
23398860
24.

Evaluation of the cobas 4800 CT/NG Test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae DNA in urogenital swabs and urine specimens.

Parra-Sánchez M, Palomares JC, Bernal S, González MT, Sivianes N, Pérez L, Pueyo I, Martín-Mazuelos E.

Diagn Microbiol Infect Dis. 2012 Dec;74(4):338-42. doi: 10.1016/j.diagmicrobio.2012.08.004. Epub 2012 Sep 17.

PMID:
22995365
25.

Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions.

León C, Ruiz-Santana S, Saavedra P, Castro C, Ubeda A, Loza A, Martín-Mazuelos E, Blanco A, Jerez V, Ballús J, Alvarez-Rocha L, Utande-Vázquez A, Fariñas O.

Intensive Care Med. 2012 Aug;38(8):1315-25. doi: 10.1007/s00134-012-2616-y. Epub 2012 Jun 30.

PMID:
22752333
26.

Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus spp.

Martos AI, Martín-Mazuelos E, Romero A, Serrano C, González T, Almeida C, Puche B, Cantón E, Pemán J, Espinel-Ingroff A.

Diagn Microbiol Infect Dis. 2012 May;73(1):53-6. doi: 10.1016/j.diagmicrobio.2012.01.006. Epub 2012 Apr 4.

PMID:
22480568
27.

Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution.

Pfaller MA, Espinel-Ingroff A, Canton E, Castanheira M, Cuenca-Estrella M, Diekema DJ, Fothergill A, Fuller J, Ghannoum M, Jones RN, Lockhart SR, Martin-Mazuelos E, Melhem MS, Ostrosky-Zeichner L, Pappas P, Pelaez T, Peman J, Rex J, Szeszs MW.

J Clin Microbiol. 2012 Jun;50(6):2040-6. doi: 10.1128/JCM.00248-12. Epub 2012 Mar 29.

28.

Comparison of the Cobas 4800 Human Papillomavirus test against a combination of the Amplicor Human Papillomavirus and the Linear Array tests for detection of HPV types 16 and 18 in cervical samples.

Martínez SB, Palomares JC, Artura A, Parra M, Cabezas JL, Romo JM, Martín-Mazuelos E.

J Virol Methods. 2012 Mar;180(1-2):7-10. doi: 10.1016/j.jviromet.2011.12.002. Epub 2011 Dec 14.

PMID:
22197189
29.

[Evaluation of the cobas 4800 CT/NG test for detecting Chlamydia trachomatis].

Parra M, Palomares JC, Bernal S, Sivianes N, Pérez L, Pueyo I, Almeida C, Martín-Mazuelos E.

Enferm Infecc Microbiol Clin. 2011 Jun-Jul;29(6):421-4. doi: 10.1016/j.eimc.2011.01.016. Epub 2011 May 4. Spanish.

PMID:
21546129
30.

[Candidemias: multicentre analysis in 16 hospitals in Andalusia (Spain)].

Rodríguez-Hernández MJ, Ruiz-Pérez de Pipaon M, Márquez-Solero M, Martín-Rico P, Castón-Osorio JJ, Guerrero-Sánchez FM, Vidal-Verdú E, García-Figueras C, Del Arco-Jiménez A, Rodríguez-Baño J, Martín-Mazuelos E, Cisneros-Herreros JM; por el Grupo de Investigadores de la Sociedad Andaluza de Microbiología y Parasitología (SAMPAC) y de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI).

Enferm Infecc Microbiol Clin. 2011 May;29(5):328-33. doi: 10.1016/j.eimc.2010.12.003. Epub 2011 Apr 8. Spanish.

PMID:
21477895
31.

Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients.

Pemán J, Zaragoza R, Quindós G, Alkorta M, Cuétara MS, Camarena JJ, Ramírez P, Giménez MJ, Martín-Mazuelos E, Linares-Sicilia MJ, Pontón J; study group Candida albicans Germ Tube Antibody Detection in Critically Ill Patients.

BMC Infect Dis. 2011 Mar 9;11:60. doi: 10.1186/1471-2334-11-60.

32.

[Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: results from the FUNGEMYCA study].

Pemán J, Cantón E, Miñana JJ, Florez JA, Echeverria J, Ortega DN, Alarcón JM, Fontanals D, Sard BG, Moreno BB, Torroba L, Ayats J, Pérez MÁ, Fernández MA, Reus FS, Natal IF, García GR, Ezpeleta G, Martín-Mazuelos E, Iglesias I, Rezusta A, de Ocariz IR, Nieto AG; el Grupo de Estudio FUNGEMYCA.

Rev Iberoam Micol. 2011 Apr-Jun;28(2):91-9. doi: 10.1016/j.riam.2011.02.005. Epub 2011 Mar 3. Spanish.

PMID:
21376831
33.

[Prevalence and risk factors of methicillin-resistant Staphylococcus aureus colonization among residents living in long-term care facilities in southern Spain].

García-García JA, Santos-Morano J, Castro C, Bayoll-Serradilla E, Martín-Ponce ML, Vergara-López S, Martín-Rodríguez LM, Mateos-Gómez A, de la Cueva J, Martín-Mazuelos E, Gómez-Mateos JM, Corzo-Delgado JE.

Enferm Infecc Microbiol Clin. 2011 Jun-Jul;29(6):405-10. doi: 10.1016/j.eimc.2010.12.010. Epub 2011 Feb 24. Spanish.

PMID:
21349606
34.

[Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 update].

Ayats J, Martín-Mazuelos E, Pemán J, Quindós G, Sánchez F, García-Rodríguez J, Guarro J, Guinea J, Linares MJ, Pontón J, Rodríguez-Tudela JL, Cuenca-Estrella M; Grupo de Estudio de Micología Médica de la SEIMC (GEMICOMED).

Enferm Infecc Microbiol Clin. 2011 Jan;29(1):39.e1-15. doi: 10.1016/j.eimc.2010.08.005. Epub 2010 Dec 22. Spanish.

PMID:
21183253
35.

Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins.

Martos AI, Romero A, González MT, González A, Serrano C, Castro C, Pemán J, Cantón E, Martín-Mazuelos E.

Med Mycol. 2010 Sep;48(6):858-61. doi: 10.3109/13693781003586943.

PMID:
20144131
36.

Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method.

Cejudo MA, Gallego AG, Lacasa EC, Aller AI, Romero A, García JP, Andrés GQ, Martín-Mazuelos E.

Med Mycol. 2010 Aug;48(5):710-9. doi: 10.3109/13693780903473343.

PMID:
20109092
37.

Isolation of Moellerella wisconsensis from blood culture from a patient with acute cholecystitis.

Aller AI, Castro C, Medina MJ, González MT, Sevilla P, Morilla MD, Corzo JE, Martín-Mazuelos E.

Clin Microbiol Infect. 2009 Dec;15(12):1193-4. doi: 10.1111/j.1469-0691.2009.03046.x. Epub 2009 Sep 2. No abstract available.

38.

[In vitro activity of anidulafungin. Comparison with the activity of other echinocandins].

Martín Mazuelos E, Rodríguez-Tudela JL.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 14:7-13. Review. Spanish.

PMID:
19572429
39.

In vitro susceptibilities of bloodstream isolates of Candida spp.: results from a multicenter active surveillance program in Andalusia.

Flórez C, Martín-Mazuelos E, Ruiz M, Cisneros JM, Herrero M, García MV, Márquez M, Porras J, Martín P, Gamero C, Castón JJ; Grupo de Estudio de las Candidemias en Andalucía (Andalusian Study Group for Candidemia).

Enferm Infecc Microbiol Clin. 2009 Nov;27(9):518-22. doi: 10.1016/j.eimc.2008.09.013. Epub 2009 May 23. Erratum in: Enferm Infecc Microbiol Clin. 2010 Jun-Jul;28(6):405. García, Ma Victoria [corrected to García, M Victoria].

PMID:
19477048
40.

Comparison of the Sensititre YeastOne colorimetric antifungal panel with the modified Clinical and Laboratory Standards Institute broth microdilution (M38-A) method for antifungal susceptibility testing of dermatophytes.

Castro C, Serrano MC, Valverde A, Pemán J, Almeida C, Martín-Mazuelos E.

Chemotherapy. 2008;54(6):427-30. doi: 10.1159/000158661. Epub 2008 Sep 30.

PMID:
18824849
41.

Molecular detection and identification of Aspergillus spp. from clinical samples using real-time PCR.

Ramírez M, Castro C, Palomares JC, Torres MJ, Aller AI, Ruiz M, Aznar J, Martín-Mazuelos E.

Mycoses. 2009 Mar;52(2):129-34. doi: 10.1111/j.1439-0507.2008.01548.x. Epub 2008 Jul 15.

PMID:
18643921
42.

Multicenter survey of in vitro antifungal resistance in yeasts of medical importance isolated from Spanish patients.

Quindós G, Abarca L, Carrillo-Muñoz AJ, Arévalo MP, Bornay FJ, Casals JB, Hernández-Molina JM, Iglesias I, Linares MJ, Martín-Mazuelos E, Pereiro Ferreirós M, Rezusta A, Rubio MC, Salesa R, San Millán R, Torres-Rodríguez JM.

Rev Iberoam Micol. 1999 Jun;16(2):97-100.

43.

Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing.

Carrillo-Muñoz AJ, Abarca L, Quindós G, Arévalo P, Bornay F, Cabañes FJ, Casals JB, Estivill D, Gonzalez-Lama Z, Iglesias I, Hernández-Molina JM, Linares MJ, Martín-Mazuelos E, Payá MJ, Pereiro M Jr, San Millán R, Rubio MC.

Rev Iberoam Micol. 1999 Jun;16(2):92-6.

44.

Activity of BAL 4815 against filamentous fungi.

Martín de la Escalera C, Aller AI, López-Oviedo E, Romero A, Martos AI, Cantón E, Pemán J, García Martos P, Martín-Mazuelos E.

J Antimicrob Chemother. 2008 May;61(5):1083-6. doi: 10.1093/jac/dkn076. Epub 2008 Mar 7.

PMID:
18326856
45.

Comparison of E-Test, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes.

Méndez CC, Serrano MC, Valverde A, Pemán J, Almeida C, Martín-Mazuelos E.

Med Mycol. 2008 Mar;46(2):119-23. doi: 10.1080/13693780701670491.

PMID:
18324490
46.

Comparison of disc diffusion assay with the CLSI reference method (M27-A2) for testing in vitro posaconazole activity against common and uncommon yeasts.

Cantón E, Pemán J, Espinel-Ingroff A, Martín-Mazuelos E, Carrillo-Muñoz A, Martínez JP.

J Antimicrob Chemother. 2008 Jan;61(1):135-8. Epub 2007 Nov 22.

PMID:
18033784
47.

Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994-1996 and 1997-2005.

Aller AI, Claro R, Castro C, Serrano C, Colom MF, Martín-Mazuelos E.

Chemotherapy. 2007;53(4):300-5. Epub 2007 May 10.

PMID:
17496416
48.

[Evolution of HIV resistance mutations in the Valme referral center].

Nogales MC, Castro C, Martín-Mazuelos E.

Enferm Infecc Microbiol Clin. 2007 Feb;25(2):159. Spanish. No abstract available.

PMID:
17288915
49.

Comparative study of disc diffusion and microdilution methods in susceptibility testing of micafungin against Candida species.

Ramírez M, Serrano MC, Castro C, López E, Almeida C, Fernández A, Romero A, Martín-Mazuelos E.

J Antimicrob Chemother. 2006 Oct;58(4):861-3. Epub 2006 Aug 17.

PMID:
16916868
50.

Evaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi: comparison with CLSI broth microdilution method.

López-Oviedo E, Aller AI, Martín C, Castro C, Ramirez M, Pemán JM, Cantón E, Almeida C, Martín-Mazuelos E.

Antimicrob Agents Chemother. 2006 Mar;50(3):1108-11.

Supplemental Content

Loading ...
Support Center